{"id":16676,"date":"2026-06-17T16:35:20","date_gmt":"2026-06-17T14:35:20","guid":{"rendered":"https:\/\/www.interpharma.ch\/?p=16676"},"modified":"2026-06-24T10:01:40","modified_gmt":"2026-06-24T08:01:40","slug":"3-questions-a-notre-nouveau-membre-du-conseil-dadministration-rea-lal-country-lead-de-pfizer-switzerland","status":"publish","type":"post","link":"https:\/\/www.interpharma.ch\/fr\/blog\/3-questions-a-notre-nouveau-membre-du-conseil-dadministration-rea-lal-country-lead-de-pfizer-switzerland\/","title":{"rendered":"3 questions \u00e0 notre nouveau membre du conseil d\u2019administration: Rea Lal, Country Lead de Pfizer Switzerland"},"content":{"rendered":"\n<figure class=\"wp-block-image size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"949\" height=\"949\" src=\"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2026\/06\/Reas-Portrait-2.jpg\" alt=\"\" class=\"wp-image-16691\" srcset=\"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2026\/06\/Reas-Portrait-2.jpg 949w, https:\/\/www.interpharma.ch\/wp-content\/uploads\/2026\/06\/Reas-Portrait-2-800x800.jpg 800w, https:\/\/www.interpharma.ch\/wp-content\/uploads\/2026\/06\/Reas-Portrait-2-300x300.jpg 300w, https:\/\/www.interpharma.ch\/wp-content\/uploads\/2026\/06\/Reas-Portrait-2-768x768.jpg 768w\" sizes=\"auto, (max-width: 949px) 100vw, 949px\" \/><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-dans-le-contexte-geopolitique-actuel-l-industrie-pharmaceutique-suisse-est-sous-pression-en-particulier-l-acces-des-patientes-et-patients-aux-medicaments-est-menace-ou-voyez-vous-le-plus-grand-risque-pour-la-suisse\"><strong>Dans le contexte g\u00e9opolitique actuel, l\u2019industrie pharmaceutique suisse est sous pression. En particulier l\u2019acc\u00e8s des patientes et patients aux m\u00e9dicaments est menac\u00e9. O\u00f9 voyez-vous le plus grand risque pour la Suisse?<\/strong><\/h2>\n\n\n\n<p>Par la clause dite de la nation la plus favoris\u00e9e ou \u00abMost Favored Nation\u00bb (MFN), les \u00c9tats-Unis relient \u00e0 l\u2019avenir les prix am\u00e9ricains des m\u00e9dicaments \u00e0 ceux, en parit\u00e9 de pouvoir d\u2019achat, d\u2019autres pays riches, dont la Suisse. Cela veut dire que la formation des prix sur le petit march\u00e9 qu\u2019est la Suisse a une influence directe sur le march\u00e9 am\u00e9ricain qui est le plus grand march\u00e9 pharmaceutique au monde. Pour les entreprises, cela cr\u00e9e un dilemme: des prix bas en Suisse peuvent \u00eatre dommageables pour la formation des prix aux \u00c9tats-Unis. Cela accro\u00eet le risque que l\u2019arriv\u00e9e de traitements innovants en Suisse soit retard\u00e9e ou ne soit pas prioris\u00e9e, avec \u00e0 la cl\u00e9, un acc\u00e8s limit\u00e9 aux innovations en Suisse.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-quelles-mesures-concretes-estimez-vous-necessaires-pour-reduire-les-retards-actuels-dans-la-formation-des-prix-et-la-prise-en-charge-et-accelerer-l-acces-des-patientes-et-patients-de-suisse-aux-traitements-innovants\"><strong><strong><strong><strong>Quelles mesures concr\u00e8tes estimez-vous n\u00e9cessaires pour r\u00e9duire les retards actuels dans la formation des prix et la prise en charge et acc\u00e9l\u00e9rer l\u2019acc\u00e8s des patientes et patients de Suisse aux traitements innovants?<\/strong><\/strong><\/strong><\/strong><\/h2>\n\n\n\n<p>Nous avons besoin d\u2019une modernisation du syst\u00e8me des prix pour que le prix r\u00e9compense l\u2019innovation de mani\u00e8re ad\u00e9quate.<br>Un exemple: lors de la fixation du prix, on utilise entre autres ce que l\u2019on appelle la \u00abcomparaison th\u00e9rapeutique\u00bb, c\u2019est-\u00e0-dire une comparaison entre diff\u00e9rents m\u00e9dicaments pour le traitement de la m\u00eame maladie. En oncologie, cela peut avoir pour effet qu\u2019un nouveau traitement sera compar\u00e9 avec d\u2019autres plus anciens, qui ne sont plus d\u2019actualit\u00e9 en clinique. C\u2019est pourquoi nous sugg\u00e9rons entre autres un choix compr\u00e9hensible des traitements de comparaison sur la base de la comparabilit\u00e9 clinique et non d\u2019un point de vue focalis\u00e9 isol\u00e9ment sur la r\u00e9duction des co\u00fbts. Nous pr\u00e9conisons pour cela d\u2019inclure des expertes et experts cliniques ind\u00e9pendants.<br>Nous voulons continuer \u00e0 nous impliquer de mani\u00e8re constructive dans l\u2019\u00e9laboration de solutions qui permettent un acc\u00e8s rapide \u00e0 l\u2019innovation dans le cadre d\u2019une syst\u00e8me de sant\u00e9 au financement p\u00e9renne. Mais pour cela, il faut un changement de perspective.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-de-quelle-maniere-souhaitez-vous-participer-au-comite-directeur-d-interpharma\"><strong><strong><strong><strong>De quelle mani\u00e8re souhaitez-vous participer au comit\u00e9 directeur d\u2019Interpharma?<\/strong><\/strong><\/strong><\/strong><\/h2>\n\n\n\n<p>Le syst\u00e8me politique suisse met l\u2019accent sur la concertation entre diff\u00e9rents acteurs pour aboutir \u00e0 des solutions majoritaires. Cette orientation vers le consensus est une force de la place suisse.<br>Coop\u00e9rer, rechercher ensemble des solutions viables et nouer des alliances est quelque chose qui m\u2019a toujours motiv\u00e9e dans ma carri\u00e8re. J\u2019ai pu ainsi construire des passerelles, par exemple dans le domaine des vaccins. Il existe un large consensus sur l\u2019importance d\u2019am\u00e9liorer la couverture vaccinale des groupes \u00e0 risque. Je m\u2019investis en ce sens pour r\u00e9unir des acteurs pertinents et discuter et mettre en \u0153uvre ensemble des mesures concr\u00e8tes, par exemple pour accro\u00eetre les comp\u00e9tences de la population en mati\u00e8re de vaccination ou renforcer le r\u00f4le des pharmacies.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Rea Lal, Country Lead de Pfizer Switzerland<\/p>\n","protected":false},"author":12,"featured_media":16686,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"tags":[59,120,130,149,182],"class_list":["post-16676","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","tag-forschung","tag-innovation-fr","tag-pharmastandort-2030-fr","tag-recherche-et-developpement"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.2 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>3 questions \u00e0 notre nouveau membre du conseil d\u2019administration: Rea Lal, Country Lead de Pfizer Switzerland - Interpharma<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.interpharma.ch\/fr\/blog\/3-questions-a-notre-nouveau-membre-du-conseil-dadministration-rea-lal-country-lead-de-pfizer-switzerland\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"3 questions \u00e0 notre nouveau membre du conseil d\u2019administration: Rea Lal, Country Lead de Pfizer Switzerland\" \/>\n<meta property=\"og:description\" content=\"Rea Lal, Country Lead de Pfizer Switzerland\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.interpharma.ch\/fr\/blog\/3-questions-a-notre-nouveau-membre-du-conseil-dadministration-rea-lal-country-lead-de-pfizer-switzerland\/\" \/>\n<meta property=\"og:site_name\" content=\"Interpharma\" \/>\n<meta property=\"article:published_time\" content=\"2026-06-17T14:35:20+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-06-24T08:01:40+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2026\/06\/Reas-Portrait.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"949\" \/>\n\t<meta property=\"og:image:height\" content=\"949\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"livantonsen\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@interpharma_ch\" \/>\n<meta name=\"twitter:site\" content=\"@interpharma_ch\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"livantonsen\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.interpharma.ch\/fr\/blog\/3-questions-a-notre-nouveau-membre-du-conseil-dadministration-rea-lal-country-lead-de-pfizer-switzerland\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.interpharma.ch\/fr\/blog\/3-questions-a-notre-nouveau-membre-du-conseil-dadministration-rea-lal-country-lead-de-pfizer-switzerland\/\"},\"author\":{\"name\":\"livantonsen\",\"@id\":\"https:\/\/www.interpharma.ch\/#\/schema\/person\/7d959c3353600fdf7ed5dde22078d158\"},\"headline\":\"3 questions \u00e0 notre nouveau membre du conseil d\u2019administration: Rea Lal, Country Lead de Pfizer Switzerland\",\"datePublished\":\"2026-06-17T14:35:20+00:00\",\"dateModified\":\"2026-06-24T08:01:40+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.interpharma.ch\/fr\/blog\/3-questions-a-notre-nouveau-membre-du-conseil-dadministration-rea-lal-country-lead-de-pfizer-switzerland\/\"},\"wordCount\":554,\"publisher\":{\"@id\":\"https:\/\/www.interpharma.ch\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.interpharma.ch\/fr\/blog\/3-questions-a-notre-nouveau-membre-du-conseil-dadministration-rea-lal-country-lead-de-pfizer-switzerland\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2026\/06\/Reas-Portrait.jpg\",\"keywords\":[\"Forschung\",\"Innovation\",\"Pharmastandort 2030\",\"recherche et d\u00e9veloppement\",\"Forschung\"],\"inLanguage\":\"fr-FR\",\"copyrightYear\":\"2026\",\"copyrightHolder\":{\"@id\":\"https:\/\/www.interpharma.ch\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.interpharma.ch\/fr\/blog\/3-questions-a-notre-nouveau-membre-du-conseil-dadministration-rea-lal-country-lead-de-pfizer-switzerland\/\",\"url\":\"https:\/\/www.interpharma.ch\/fr\/blog\/3-questions-a-notre-nouveau-membre-du-conseil-dadministration-rea-lal-country-lead-de-pfizer-switzerland\/\",\"name\":\"3 questions \u00e0 notre nouveau membre du conseil d\u2019administration: Rea Lal, Country Lead de Pfizer Switzerland - Interpharma\",\"isPartOf\":{\"@id\":\"https:\/\/www.interpharma.ch\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.interpharma.ch\/fr\/blog\/3-questions-a-notre-nouveau-membre-du-conseil-dadministration-rea-lal-country-lead-de-pfizer-switzerland\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.interpharma.ch\/fr\/blog\/3-questions-a-notre-nouveau-membre-du-conseil-dadministration-rea-lal-country-lead-de-pfizer-switzerland\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2026\/06\/Reas-Portrait.jpg\",\"datePublished\":\"2026-06-17T14:35:20+00:00\",\"dateModified\":\"2026-06-24T08:01:40+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.interpharma.ch\/fr\/blog\/3-questions-a-notre-nouveau-membre-du-conseil-dadministration-rea-lal-country-lead-de-pfizer-switzerland\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.interpharma.ch\/fr\/blog\/3-questions-a-notre-nouveau-membre-du-conseil-dadministration-rea-lal-country-lead-de-pfizer-switzerland\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.interpharma.ch\/fr\/blog\/3-questions-a-notre-nouveau-membre-du-conseil-dadministration-rea-lal-country-lead-de-pfizer-switzerland\/#primaryimage\",\"url\":\"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2026\/06\/Reas-Portrait.jpg\",\"contentUrl\":\"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2026\/06\/Reas-Portrait.jpg\",\"width\":949,\"height\":949},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.interpharma.ch\/fr\/blog\/3-questions-a-notre-nouveau-membre-du-conseil-dadministration-rea-lal-country-lead-de-pfizer-switzerland\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\/\/www.interpharma.ch\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"3 questions \u00e0 notre nouveau membre du conseil d\u2019administration: Rea Lal, Country Lead de Pfizer Switzerland\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.interpharma.ch\/#website\",\"url\":\"https:\/\/www.interpharma.ch\/\",\"name\":\"Interpharma\",\"description\":\"Verband der forschenden Pharmazeutischen Firmen\",\"publisher\":{\"@id\":\"https:\/\/www.interpharma.ch\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.interpharma.ch\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.interpharma.ch\/#organization\",\"name\":\"Interpharma\",\"url\":\"https:\/\/www.interpharma.ch\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.interpharma.ch\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/interpharma.ch\/wp-content\/uploads\/2026\/03\/20251014_iph_logo_wort_bildmarke_rgb_final_cu01.svg\",\"contentUrl\":\"https:\/\/interpharma.ch\/wp-content\/uploads\/2026\/03\/20251014_iph_logo_wort_bildmarke_rgb_final_cu01.svg\",\"width\":\"1200\",\"height\":\"1200\",\"caption\":\"Interpharma\"},\"image\":{\"@id\":\"https:\/\/www.interpharma.ch\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/x.com\/interpharma_ch\",\"https:\/\/ch.linkedin.com\/company\/interpharma\",\"https:\/\/www.instagram.com\/interpharma_ch\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.interpharma.ch\/#\/schema\/person\/7d959c3353600fdf7ed5dde22078d158\",\"name\":\"livantonsen\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/381670883a2bb428497a0e409bd947df62cefce2a71135b42fb98e92196bfabc?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/381670883a2bb428497a0e409bd947df62cefce2a71135b42fb98e92196bfabc?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/381670883a2bb428497a0e409bd947df62cefce2a71135b42fb98e92196bfabc?s=96&d=mm&r=g\",\"caption\":\"livantonsen\"}}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"3 questions \u00e0 notre nouveau membre du conseil d\u2019administration: Rea Lal, Country Lead de Pfizer Switzerland - Interpharma","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.interpharma.ch\/fr\/blog\/3-questions-a-notre-nouveau-membre-du-conseil-dadministration-rea-lal-country-lead-de-pfizer-switzerland\/","og_locale":"fr_FR","og_type":"article","og_title":"3 questions \u00e0 notre nouveau membre du conseil d\u2019administration: Rea Lal, Country Lead de Pfizer Switzerland","og_description":"Rea Lal, Country Lead de Pfizer Switzerland","og_url":"https:\/\/www.interpharma.ch\/fr\/blog\/3-questions-a-notre-nouveau-membre-du-conseil-dadministration-rea-lal-country-lead-de-pfizer-switzerland\/","og_site_name":"Interpharma","article_published_time":"2026-06-17T14:35:20+00:00","article_modified_time":"2026-06-24T08:01:40+00:00","og_image":[{"width":949,"height":949,"url":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2026\/06\/Reas-Portrait.jpg","type":"image\/jpeg"}],"author":"livantonsen","twitter_card":"summary_large_image","twitter_creator":"@interpharma_ch","twitter_site":"@interpharma_ch","twitter_misc":{"\u00c9crit par":"livantonsen","Dur\u00e9e de lecture estim\u00e9e":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.interpharma.ch\/fr\/blog\/3-questions-a-notre-nouveau-membre-du-conseil-dadministration-rea-lal-country-lead-de-pfizer-switzerland\/#article","isPartOf":{"@id":"https:\/\/www.interpharma.ch\/fr\/blog\/3-questions-a-notre-nouveau-membre-du-conseil-dadministration-rea-lal-country-lead-de-pfizer-switzerland\/"},"author":{"name":"livantonsen","@id":"https:\/\/www.interpharma.ch\/#\/schema\/person\/7d959c3353600fdf7ed5dde22078d158"},"headline":"3 questions \u00e0 notre nouveau membre du conseil d\u2019administration: Rea Lal, Country Lead de Pfizer Switzerland","datePublished":"2026-06-17T14:35:20+00:00","dateModified":"2026-06-24T08:01:40+00:00","mainEntityOfPage":{"@id":"https:\/\/www.interpharma.ch\/fr\/blog\/3-questions-a-notre-nouveau-membre-du-conseil-dadministration-rea-lal-country-lead-de-pfizer-switzerland\/"},"wordCount":554,"publisher":{"@id":"https:\/\/www.interpharma.ch\/#organization"},"image":{"@id":"https:\/\/www.interpharma.ch\/fr\/blog\/3-questions-a-notre-nouveau-membre-du-conseil-dadministration-rea-lal-country-lead-de-pfizer-switzerland\/#primaryimage"},"thumbnailUrl":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2026\/06\/Reas-Portrait.jpg","keywords":["Forschung","Innovation","Pharmastandort 2030","recherche et d\u00e9veloppement","Forschung"],"inLanguage":"fr-FR","copyrightYear":"2026","copyrightHolder":{"@id":"https:\/\/www.interpharma.ch\/#organization"}},{"@type":"WebPage","@id":"https:\/\/www.interpharma.ch\/fr\/blog\/3-questions-a-notre-nouveau-membre-du-conseil-dadministration-rea-lal-country-lead-de-pfizer-switzerland\/","url":"https:\/\/www.interpharma.ch\/fr\/blog\/3-questions-a-notre-nouveau-membre-du-conseil-dadministration-rea-lal-country-lead-de-pfizer-switzerland\/","name":"3 questions \u00e0 notre nouveau membre du conseil d\u2019administration: Rea Lal, Country Lead de Pfizer Switzerland - Interpharma","isPartOf":{"@id":"https:\/\/www.interpharma.ch\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.interpharma.ch\/fr\/blog\/3-questions-a-notre-nouveau-membre-du-conseil-dadministration-rea-lal-country-lead-de-pfizer-switzerland\/#primaryimage"},"image":{"@id":"https:\/\/www.interpharma.ch\/fr\/blog\/3-questions-a-notre-nouveau-membre-du-conseil-dadministration-rea-lal-country-lead-de-pfizer-switzerland\/#primaryimage"},"thumbnailUrl":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2026\/06\/Reas-Portrait.jpg","datePublished":"2026-06-17T14:35:20+00:00","dateModified":"2026-06-24T08:01:40+00:00","breadcrumb":{"@id":"https:\/\/www.interpharma.ch\/fr\/blog\/3-questions-a-notre-nouveau-membre-du-conseil-dadministration-rea-lal-country-lead-de-pfizer-switzerland\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.interpharma.ch\/fr\/blog\/3-questions-a-notre-nouveau-membre-du-conseil-dadministration-rea-lal-country-lead-de-pfizer-switzerland\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.interpharma.ch\/fr\/blog\/3-questions-a-notre-nouveau-membre-du-conseil-dadministration-rea-lal-country-lead-de-pfizer-switzerland\/#primaryimage","url":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2026\/06\/Reas-Portrait.jpg","contentUrl":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2026\/06\/Reas-Portrait.jpg","width":949,"height":949},{"@type":"BreadcrumbList","@id":"https:\/\/www.interpharma.ch\/fr\/blog\/3-questions-a-notre-nouveau-membre-du-conseil-dadministration-rea-lal-country-lead-de-pfizer-switzerland\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/www.interpharma.ch\/fr\/"},{"@type":"ListItem","position":2,"name":"3 questions \u00e0 notre nouveau membre du conseil d\u2019administration: Rea Lal, Country Lead de Pfizer Switzerland"}]},{"@type":"WebSite","@id":"https:\/\/www.interpharma.ch\/#website","url":"https:\/\/www.interpharma.ch\/","name":"Interpharma","description":"Verband der forschenden Pharmazeutischen Firmen","publisher":{"@id":"https:\/\/www.interpharma.ch\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.interpharma.ch\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.interpharma.ch\/#organization","name":"Interpharma","url":"https:\/\/www.interpharma.ch\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.interpharma.ch\/#\/schema\/logo\/image\/","url":"https:\/\/interpharma.ch\/wp-content\/uploads\/2026\/03\/20251014_iph_logo_wort_bildmarke_rgb_final_cu01.svg","contentUrl":"https:\/\/interpharma.ch\/wp-content\/uploads\/2026\/03\/20251014_iph_logo_wort_bildmarke_rgb_final_cu01.svg","width":"1200","height":"1200","caption":"Interpharma"},"image":{"@id":"https:\/\/www.interpharma.ch\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/interpharma_ch","https:\/\/ch.linkedin.com\/company\/interpharma","https:\/\/www.instagram.com\/interpharma_ch\/"]},{"@type":"Person","@id":"https:\/\/www.interpharma.ch\/#\/schema\/person\/7d959c3353600fdf7ed5dde22078d158","name":"livantonsen","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/381670883a2bb428497a0e409bd947df62cefce2a71135b42fb98e92196bfabc?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/381670883a2bb428497a0e409bd947df62cefce2a71135b42fb98e92196bfabc?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/381670883a2bb428497a0e409bd947df62cefce2a71135b42fb98e92196bfabc?s=96&d=mm&r=g","caption":"livantonsen"}}]}},"_links":{"self":[{"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/posts\/16676","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/users\/12"}],"replies":[{"embeddable":true,"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/comments?post=16676"}],"version-history":[{"count":1,"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/posts\/16676\/revisions"}],"predecessor-version":[{"id":16692,"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/posts\/16676\/revisions\/16692"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/media\/16686"}],"wp:attachment":[{"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/media?parent=16676"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/tags?post=16676"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}